Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

1 year ago

Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash. 

More Stories

Germany’s CDU ahead in election exit poll, strong support for far right

2 hours ago

Why has Israel suspended the release of Palestinian prisoners?

2 hours ago

German election 2025 live results: By the numbers

2 hours ago

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

The fact of the past between El-Rufai and Ribadu, By Yushau A. Shuaib

47 mins ago

Don’t urinate on their graves!, By Wole Olaoye

47 mins ago

Rangers sack Clement

47 mins ago

Nigeria records 80 deaths from Lassa fever in one week

2 hours ago

AfroBasket 2025: Resurgent D’Tigers seal qualification in grand style

2 hours ago